Abstract
The development of a good biocompatible matrix for immobilization of cells is very crucial for improving the performance of functional biohybrids. The synthesis of solid inorganic materials from alkoxide, aqueous and polyolmodified silanes routes, as well as the incorporation of organic polymers, are further areas being developed to improve the viability of encapsulated cells. This emerging field of material science has generated considerable and increasing interest during the past decade. Recent advances in the field involving biomaterials, biohybrids, and functional nanomaterials provided novel materials, which have gained the attention of the scientific community, Governments and industrial companies. Overall, this review is intended to give an overview on the current state of the art of the patents associated to the immobilization of whole living cells in sol-gel derived hybrid materials and to describe the major challenges to be addressed in the forthcoming years.
Keywords: Sol-gel, whole cell immobilization, hybrid materials, biomedical applications
Recent Patents on Biotechnology
Title: Development of Sol-Gel Hybrid Materials for Whole Cell Immobilization
Volume: 3 Issue: 1
Author(s): Martin F. Desimone, Gisela S. Alvarez, Maria L. Foglia and Luis E. Diaz
Affiliation:
Keywords: Sol-gel, whole cell immobilization, hybrid materials, biomedical applications
Abstract: The development of a good biocompatible matrix for immobilization of cells is very crucial for improving the performance of functional biohybrids. The synthesis of solid inorganic materials from alkoxide, aqueous and polyolmodified silanes routes, as well as the incorporation of organic polymers, are further areas being developed to improve the viability of encapsulated cells. This emerging field of material science has generated considerable and increasing interest during the past decade. Recent advances in the field involving biomaterials, biohybrids, and functional nanomaterials provided novel materials, which have gained the attention of the scientific community, Governments and industrial companies. Overall, this review is intended to give an overview on the current state of the art of the patents associated to the immobilization of whole living cells in sol-gel derived hybrid materials and to describe the major challenges to be addressed in the forthcoming years.
Export Options
About this article
Cite this article as:
Desimone F. Martin, Alvarez S. Gisela, Foglia L. Maria and Diaz E. Luis, Development of Sol-Gel Hybrid Materials for Whole Cell Immobilization, Recent Patents on Biotechnology 2009; 3 (1) . https://dx.doi.org/10.2174/187220809787172605
DOI https://dx.doi.org/10.2174/187220809787172605 |
Print ISSN 1872-2083 |
Publisher Name Bentham Science Publisher |
Online ISSN 2212-4012 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Type 1 Diabetes in Young Adulthood
Current Diabetes Reviews Molecular Interaction Study of N1-p-fluorobenzyl-cymserine with TNF-α , p38 Kinase and JNK Kinase
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry Development of Peptide and Protein Based Radiopharmaceuticals
Current Pharmaceutical Design Role of Thrombin Activatable Fibrinolysis Inhibitor in Endocrine and Cardiovascular Disorders: An Update
Recent Patents on Endocrine, Metabolic & Immune Drug Discovery (Discontinued) The Role of T and B Cells in Atherosclerosis: Potential Clinical Implications
Current Pharmaceutical Design Safety of Canagliflozin in Patients with Type 2 Diabetes
Current Drug Safety Nano-Therapeutics for the Lung: State-of-the-Art and Future Perspectives
Current Pharmaceutical Design Diabetes and Its Complications: Therapies Available, Anticipated and Aspired
Current Diabetes Reviews Radioprotective Effect of Gliclazide as an Anti-Hyperglycemic Agent Against Genotoxicity Induced by Ionizing Radiation on Human Lymphocytes
Cardiovascular & Hematological Agents in Medicinal Chemistry The Role of MicroRNAs in the Pancreatic Differentiation of Pluripotent Stem Cells
MicroRNA The Emerging Role of Arginase in Endothelial Dysfunction in Diabetes
Current Vascular Pharmacology Lipoprotein(a): Current Perspectives
Current Vascular Pharmacology Potential Molecular Targeted Therapeutics: Role of PI3-K/Akt/mTOR Inhibition in Cancer
Anti-Cancer Agents in Medicinal Chemistry The Effect of <i>Myrtus communis</i> Aqueous Extract-Containing Gel on Wound Healing in Streptozotocin-Induced Diabetic Rats
Current Drug Discovery Technologies Towards Newer Molecular Targets for Chronic Diabetic Complications
Current Vascular Pharmacology Vascular Endothelial Cell Growth Factor (VEGF), An Emerging Target for Cancer Chemotherapy
Current Medicinal Chemistry - Anti-Cancer Agents Hydrofiber Dressing and Wound Repair: Review of the Literature and New Patents
Recent Patents on Inflammation & Allergy Drug Discovery p38 Mitogen-Activated Protein Kinase: A Critical Node Linking Insulin Resistance and Cardiovascular Diseases in Type 2 Diabetes Mellitus
Endocrine, Metabolic & Immune Disorders - Drug Targets Impact of Immunosuppressive Drugs on the Development of Cardiac Allograft Vasculopathy
Current Vascular Pharmacology Editorial: Advances in Alzheimer Therapy: Something Old, Something New, Something Borrowed, Something Blue
Current Alzheimer Research